Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Zarate

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Molecular Psychiatry|May 12, 2004
Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiologyJ A Quiroz, J Singh, T D Gould, et al.
Psychopharmacology Bulletin|January 1, 1995
Algorithms for the treatment of schizophreniaC A Zarate, D G Daniel, B J Kinon, et al.
Psychological Medicine|February 13, 2016
Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectoriesT Kishimoto, J M Chawla, K Hagi, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|March 1, 1996
EEG abnormalities before clozapine therapy predict a good clinical response to clozapineS S Pillay, A L Stoll, M K Weiss, et al.
The Journal of Clinical Psychiatry|July 1, 1994
Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-upM D Banov, C A Zarate, M Tohen, et al.
The Journal of Clinical Psychiatry|July 1, 1997
Risperidone in the elderly: a pharmacoepidemiologic studyC A Zarate, R J Baldessarini, A J Siegel, et al.
Acta Psychiatrica Scandinavica|June 9, 2012
Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorderM G Soeiro-de-Souza, V V Dias, M L Figueira, et al.
Psychiatric Services (Washington, D.C.)|October 5, 2001
The case of Sam: multidisciplinary perspectivesJ L Geller, S Sprung, S G McCracken, et al.
Acta Psychiatrica Scandinavica|July 18, 2020
The effects of ketamine on typical and atypical depressive symptomsL T Park, D A Luckenbaugh, S J Pennybaker, et al.
Pharmacopsychiatry|June 24, 2014
Baseline vitamin B12 and folate levels do not predict improvement in depression after a single infusion of ketamineN B Lundin, M J Niciu, D A Luckenbaugh, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Molecular Psychiatry|May 12, 2004
Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiologyJ A Quiroz, J Singh, T D Gould, et al.
Psychopharmacology Bulletin|January 1, 1995
Algorithms for the treatment of schizophreniaC A Zarate, D G Daniel, B J Kinon, et al.
Psychological Medicine|February 13, 2016
Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectoriesT Kishimoto, J M Chawla, K Hagi, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|March 1, 1996
EEG abnormalities before clozapine therapy predict a good clinical response to clozapineS S Pillay, A L Stoll, M K Weiss, et al.
The Journal of Clinical Psychiatry|July 1, 1994
Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-upM D Banov, C A Zarate, M Tohen, et al.
The Journal of Clinical Psychiatry|July 1, 1997
Risperidone in the elderly: a pharmacoepidemiologic studyC A Zarate, R J Baldessarini, A J Siegel, et al.
Acta Psychiatrica Scandinavica|June 9, 2012
Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorderM G Soeiro-de-Souza, V V Dias, M L Figueira, et al.
Psychiatric Services (Washington, D.C.)|October 5, 2001
The case of Sam: multidisciplinary perspectivesJ L Geller, S Sprung, S G McCracken, et al.
Acta Psychiatrica Scandinavica|July 18, 2020
The effects of ketamine on typical and atypical depressive symptomsL T Park, D A Luckenbaugh, S J Pennybaker, et al.
Pharmacopsychiatry|June 24, 2014
Baseline vitamin B12 and folate levels do not predict improvement in depression after a single infusion of ketamineN B Lundin, M J Niciu, D A Luckenbaugh, et al.
Pageof 5